| dc.creator | Spanos K., Giannoukas A.D. | en |
| dc.date.accessioned | 2023-01-31T10:00:03Z | |
| dc.date.available | 2023-01-31T10:00:03Z | |
| dc.date.issued | 2015 | |
| dc.identifier | 10.1016/j.avsg.2015.05.012 | |
| dc.identifier.issn | 08905096 | |
| dc.identifier.uri | http://hdl.handle.net/11615/79258 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | Annals of Vascular Surgery | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941938197&doi=10.1016%2fj.avsg.2015.05.012&partnerID=40&md5=b90eba592ee4e0c4b09e9a30d91dc30a | |
| dc.subject | antihypertensive agent | en |
| dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en |
| dc.subject | antihypertensive agent | en |
| dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en |
| dc.subject | behavior therapy | en |
| dc.subject | cardiovascular disease | en |
| dc.subject | cardiovascular function | en |
| dc.subject | cardiovascular risk | en |
| dc.subject | diabetes mellitus | en |
| dc.subject | human | en |
| dc.subject | hyperlipidemia | en |
| dc.subject | hypertension | en |
| dc.subject | Letter | en |
| dc.subject | peripheral occlusive artery disease | en |
| dc.subject | priority journal | en |
| dc.subject | psychosocial care | en |
| dc.subject | smoking | en |
| dc.subject | smoking cessation | en |
| dc.subject | vascular surgeon | en |
| dc.subject | vascular surgery | en |
| dc.subject | adverse effects | en |
| dc.subject | health status | en |
| dc.subject | lifestyle | en |
| dc.subject | Peripheral Vascular Diseases | en |
| dc.subject | physician attitude | en |
| dc.subject | preventive health service | en |
| dc.subject | risk assessment | en |
| dc.subject | risk factor | en |
| dc.subject | risk reduction | en |
| dc.subject | surgeon | en |
| dc.subject | treatment outcome | en |
| dc.subject | vascular surgery | en |
| dc.subject | Antihypertensive Agents | en |
| dc.subject | Health Status | en |
| dc.subject | Humans | en |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors | en |
| dc.subject | Life Style | en |
| dc.subject | Peripheral Vascular Diseases | en |
| dc.subject | Physician's Role | en |
| dc.subject | Preventive Health Services | en |
| dc.subject | Risk Assessment | en |
| dc.subject | Risk Factors | en |
| dc.subject | Risk Reduction Behavior | en |
| dc.subject | Smoking | en |
| dc.subject | Smoking Cessation | en |
| dc.subject | Surgeons | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Vascular Surgical Procedures | en |
| dc.subject | Elsevier Inc. | en |
| dc.title | The Role of Vascular Surgeon in Promoting Vascular Health and Prevention of Cardiovascular Events | en |
| dc.type | other | en |